Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Gabrielson

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung CancerJiajia Zhang, Zhicheng Ji, Justina X Caushi, et al.
Nature Cancer|September 28, 2020
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancerValsamo Anagnostou, Noushin Niknafs, Kristen Marrone, et al.
The New England Journal of Medicine|April 17, 2018
Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M Forde, Jamie E Chaft, Kellie N Smith, et al.
Cancer Research|December 14, 2018
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung CancerValsamo Anagnostou, Patrick M Forde, James R White, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung CancerJiajia Zhang, Zhicheng Ji, Justina X Caushi, et al.
Nature Cancer|September 28, 2020
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancerValsamo Anagnostou, Noushin Niknafs, Kristen Marrone, et al.
The New England Journal of Medicine|April 17, 2018
Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M Forde, Jamie E Chaft, Kellie N Smith, et al.
Cancer Research|December 14, 2018
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung CancerValsamo Anagnostou, Patrick M Forde, James R White, et al.
Pageof 14